Roles of mTOR in Diabetic Kidney Disease

Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease and the number of patients affected is increasing worldwide. Thus, there is a need to establish a new treatment for DKD to improve the renal prognosis of diabetic patients. Recently, it has shown that intracellular metabol...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasuda-Yamahara, Mako, Kume, Shinji, Maegawa, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926630/
https://www.ncbi.nlm.nih.gov/pubmed/33671526
http://dx.doi.org/10.3390/antiox10020321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926630/
https://www.ncbi.nlm.nih.gov/pubmed/33671526
http://dx.doi.org/10.3390/antiox10020321

Ejemplares similares